Alnylam Pharmaceuticals
ALNY
#636
Rank
$40.45 B
Marketcap
$303.00
Share price
0.63%
Change (1 day)
12.30%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company